A global biotech is axing more of its Greater Washington workforce, eliminating nearly 100 positions across multiple waves of ...

A recipient of the 2025 Elite Trial Lawyers Lifetime Achievement Award, Morgan & Morgan's John Yanchunis spoke with the National Law Journal about his storied career, from bringing one of the nation’s ...

The U.S. Congressional Budget Office (CBO) cautioned that President Trumps proposed 2026 federal budgetfeaturing deep cuts to ...

Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.

Trump administration officials have defended the mass dismissals, saying they are overdue and necessary to make the department leaner and more efficient. Among the employees laid off are more than 100 ...

According to the company's global financial results for the first quarter, released in May, declines of 19 percent in the ...

Thousands of health workers lost their jobs this week after a US Supreme Court ruling cleared the way for major staffing cuts.

Other agencies are moving forward with RIFs and terminations, but official tells federal court some plans have changed.

Loss of support staff has slowed critical investigations of drug manufacturers. Little relief has materialized.

The number of employees laid off and companies letting people go increased year over year during the first half of 2025.

Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...

Cuts at the FDA are slowing inspections of overseas drug manufacturers, prompting concerns from former and current employees that medication safety could be at risk, ProPublica reported July 7. Dozens ...